Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Tobira Therapeutics, Inc. (TBRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/18/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
11/14/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
11/04/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
11/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Unknown transaction of 1,657 shares @ $28.35, valued at $47k
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Unknown transaction of 285,679 shares @ $28.35, valued at $8.1M
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 SC 13D/A Tobira Therapeutics, Inc. has filed a Schedule 13D for Tobira Therapeutics, Inc.
11/03/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/03/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/03/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/03/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/03/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/03/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
11/03/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
11/03/2016 4 Brosgart Carol L (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
11/03/2016 4 Melincoff Gwen A (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
11/03/2016 4 Cooper Jeffrey H (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Disposed/sold 13,539 options to buy @ $8.13, valued at $110.1k
Disposed/sold 15,500 options to buy @ $16.52, valued at $256.1k
Disposed/sold 17,778 options to buy @ $7.91, valued at $140.6k
11/03/2016 4 WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Unknown transaction of 243,726 shares @ $0
Disposed/sold 4,332 options to buy @ $2.96, valued at $12.8k
Disposed/sold 15,500 options to buy @ $16.52, valued at $256.1k
Disposed/sold 17,778 options to buy @ $7.91, valued at $140.6k
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/03/2016 4 Jenkins Helen (COO) has filed a Form 4 on Tobira Therapeutics, Inc.
11/03/2016 4 Peetz Christopher (CFO) has filed a Form 4 on Tobira Therapeutics, Inc.
11/03/2016 4 Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on Tobira Therapeutics, Inc.
11/03/2016 4 Fischer Laurent (CEO) has filed a Form 4 on Tobira Therapeutics, Inc.
11/02/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/02/2016 SC 13D/A Allergan plc reports a 100% stake in Tobira Therapeutics, Inc.
11/01/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
11/01/2016 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy